Previous Page  2 / 7 Next Page
Information
Show Menu
Previous Page 2 / 7 Next Page
Page Background

Page 8

Notes:

allied

academies

Microbiology: Current Research

Volume 2

International Conference on

Emerging Diseases, Outbreaks & Case Studies

&

16

th

Annual Meeting on

March 28-29, 2018 | Orlando, USA

Influenza

E

bola hit the population epicenters of three West African

countries from 2014 to 2015 and was responsible for over

11,000 deaths across Sierra Leone, Liberia, and Guinea. This

Ebola outbreak was facilitated by severe insufficiences in the

healthcare system of the affected countries and incredibly high

population density with unsanitary living conditions brought

on by absolute poverty. I had the honor to work in an Ebola

Treatment Unit (ETU) in Port Loko, Sierra Leone during 2015.

I stayed for another year after the epidemic to care for Ebola

survivors once it was over. While caring for survivors, my clinic

was one of the sites conducting semen testing for persistence

of Ebola RNA in male survivors’ semen. I will discuss several of

the landmark studies on Ebola since the outbreak concluded

including the persistence of Ebola RNA in human semen, the

efficacy of an Ebola vaccine, and the seropositivity rate of

asymptomatic contacts of Ebola patients.

Speaker Biography

Andrew Myers has completed his MD in 2011 from the University of South Florida

(USF), Morsani College of Medicine and his Residency in Internal Medicine at the

George Washington University in Washington, D.C. He is the Director of Quality for

the Division of Hospital Medicine at USF and currently working on projects to improve

sepsis outcomes and reduce hospital-acquired

C. difficile

. He has an interest in global

health and has worked in Botswana, South Africa, Sierra Leone, Dominican Republic,

and Thailand. He is a leading Medical student through research projects in up to 15

different countries annually.

e:

awm@health.usf.edu

Andrew Myers

University of South Florida, USA

Updates on Ebola viral disease breakthroughs since the 2014-2015 epidemic